Understanding Prostate Disease Aug 6, 2008
The term Benign Prostatic Hypertrophy (BPH) is used to describe the condition - Benign indicating that the condition is NOT cancerous. BPH is quite common - research studies in many populations have shown that approximately forty percent of men over 60 suffer from BPH.. (Suite101.com)
THE YOU DOCS Jul 2, 2008
Both my doctor and the urologist he sent me to told me I have benign prostatic hypertrophy, but they are not recommending surgery or medicine, just "watchful waiting." What does this mean. What will likely happen. (OregonLive, OR -- News)
Diabetic Men More Prone to Urinary Woes Mar 25, 2008
The investigators examined the associations between diabetes and signs of an enlarged prostate gland, a condition called benign prostatic hypertrophy, or BPH, that is quite common among older men and that can cause symptoms such as frequent urination and a weak urine stream. The study was made up of 2484 black and white men who were participating in studies designed to evaluate the natural history of BPH. Their average age was 56 years, and 170 (6. (MEDLINEplus)
Management of Prostate Cancer Jan 27, 2008
It could be prostate cancer, but it could also be benign prostatic hypertrophy (BPH), which involves a diffusely enlarged prostate without cancer, or prostatitis, which may result from infection of the prostate. In fact, a patient may be put on a trial of antibiotics if prostatitis is suspected; if the PSA drops after antibiotics, the cause is likely prostatitis. (Suite101.com)
Diet and medications may assist prevention of prostate cancer Sep 24, 2007
For example, dutasteride, has reduced by 50 percent the number of cancerous biopsies among men with benign prostatic hypertrophy. A large clinical trial is underway to evaluate whether this drug prevents malignant biopsies in men with elevated prostate surface antigen levels but previously negative biopsies. (EurekAlert!)
PM undergoes surgery for prostate Sep 16, 2007
"The procedure was performed to treat benign prostatic hypertrophy of the prostate. The Prime Minister is convalescing after the surgery and has had a stable post operative course," Baru told the media at PMO on Saturday afternoon ... Speaking to TOI, doctors who operated on the Prime Minister said, "Singh was suffering from benign prostatic hypertrophy (BPH) for the past three years. He will be completely alright now." Previously, he has had two minor surgeries on both wrists at the institute. (Times of India)
India's Prime Minister Manmohan Singh Has Surgery on Prostate Sep 15, 2007
Singh is recovering at the hospital after being treated for benign prostatic hypertrophy, or the enlargement of the prostate gland, the Prime Minister's office said in an e-mailed statement. He will return home on Sept. 17 after two-days of rest at the hospital, the statement said. (Bloomberg)
Prostate Specific Antigen May 18, 2007
These include benign conditions like benign prostatic hypertrophy and prostatitis. In addition, a normal level does not totally rule out the presence of prostate cancer. (Suite101.com)
New Prostate Cancer Test Better than PSA Apr 27, 2007
Getzenberg and his team measured EPCA-2 levels in the blood of 330 Hopkins patients separated into several groups: men with normal PSA levels and no evidence of disease; men with elevated PSA levels but who had negative biopsies, men with a common noncancerous prostate condition known as benign prostatic hypertrophy (BPH) who did not receive biopsies for prostate cancer, men with prostate cancer but with normal PSA levels, men with prostate cancer confined to the prostate, men with prostate... (Newsmax)
New Prostate Cancer Test May Detect More Tumors Apr 26, 2007
Getzenberg and his colleagues tried it on 35 men with severe "benign prostatic hypertrophy" -- enlargement of the prostate that sometimes makes the PSA go up but is not cancer. In eight of them, the EPCA-2 was high, suggesting that the EPCA-2 test would flag some men who turn out not to have cancer -- although probably not as many as the PSA test does. (Washington Post)
Dendreon: letter of approval for Provenge could aid buyout chances Apr 25, 2007
Bela Denes, senior director, clinical research at Spectrum Pharmaceuticals, a company which has four products in multiple Phase II trials, including Ozarelix, for the treatment of prostate cancer and benign prostatic hypertrophy, said ODAC has rejected the last 38 oncology drugs, only approving one. The scenario for Provenge will be to receive a letter of approval for its ongoing 500 patient phase III trial, with approval depending on its efficacy data in 2010. (FT.com -- Markets)
